A Study In Adults With Moderate To Severe Dermatomyositis

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 23, 2018

Primary Completion Date

May 27, 2022

Study Completion Date

November 28, 2022

Conditions
Dermatomyositis
Interventions
DRUG

PF-06823859 low

A humanized immunoglobulin neutralizing antibody

DRUG

Placebo Arm

Placebo contains histidine, sucrose, PS80, ethylene diamine, and triacetic acid

DRUG

PF-06823859 high

A humanized immunoglobulin neutralizing antibody

Trial Locations (41)

10016

New York University School of Medicine, New York

NYU Langone Health Clinical Research Center, New York

10028

Mount Sinai Doctors Dermatology, New York

19104

University of Pennsylvania, Philadelphia

28041

Hospital Universitario 12 de Octubre, Madrid

32224

Mayo Clinic Florida, Jacksonville

33125

University Of Miami Hospital, Miami

33136

University of Miami Hospital Clinical Translational Research Site (Infusion site), Miami

35233

University of Alabama at Birmingham, Birmingham

35249

The University of Alabama at Birmingham, Birmingham

35294

The University of Alabama at Birmingham, Birmingham

41010

Hospital Quiron Infanta Luisa, Seville

44195

Cleveland Clinic Foundation, Cleveland

55455

Clinical Research Unit (CRU), Minneapolis

Department of Medicine Division of Rheumatic and Autoimmune Disease, Minneapolis

Lillehei Clinical Research Unit (LCRU), Minneapolis

University of Minnesota Health Rheumatology Clinic, Minneapolis

University of Minnesota, Department of Dermatology, Minneapolis

63108

Center for Outpatient Health, St Louis

63110

Washington University School of Medicine, St Louis

66160

The University of Kansas Medical Center, Kansas City

66205

KU Clinical Research Center - Clinical and Translational Science Unit (CTSU), Fairway

72076

Universitaetsklinikum Tuebingen, Tübingen

84107

University of Utah MidValley Dermatology, Murray

84108

Center for Clinical & Translational Science, Salt Lake City

85054

Mayo Clinic Arizona Research Pharmacy, Phoenix

85259

Mayo Clinic, Scottsdale

90211

Attune Health Research Inc., Beverly Hills

94304

Freidenrich Center for Translational Research at Stanford University, Palo Alto

97239

OHSU, Center for Health and Healing CHH2, Portland

Oregon Clinical & Translational Research Institute, Portland

Oregon Health & Science University, Portland

21224-6821

Johns Hopkins Bayview Medical Center, Baltimore

02115

Brigham and Women's Hospital - ACC, Boston

Brigham and Women's Hospital - CTC, Boston

Brigham and Women's Hospital - CTH, Boston

Brigham and Women's Hospital, Boston

75390-9191

University of Texas Southwestern Medical Center, Dallas

H-4032

University of Debrecen, Debrecen

15-707

Nova Reuma spolka partnerska, Bialystok

30-363

Centrum Medyczne Plejady, Krakow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03181893 - A Study In Adults With Moderate To Severe Dermatomyositis | Biotech Hunter | Biotech Hunter